Product Details:
| Strength | 12.5 mg |
| Packing | Box |
| Brand | Sutinat |
| Manufacturer | Natco Pharma Limited |
| Treatment | Treat Adults With Gastrointestinal Stromal Tumor |
| Packaging Size | 28 Capsules |
| Composition | Sunitinib Malate |
Sutinat contains Sunitinib Malate, a targeted cancer therapy classified as a multi-targeted receptor tyrosine kinase (RTK) inhibitor. It is used in the treatment of various types of cancers by inhibiting tumor growth and angiogenesis (blood vessel formation).